Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Arya Sciences Acquisition Corp IV Cl A (ARYD)
Arya Sciences Acquisition Corp IV Cl A (ARYD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 88,786
  • Shares Outstanding, K 7,927
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,070 K
  • 60-Month Beta -0.01
  • Price/Sales N/A
  • Price/Cash Flow 44.59
  • Price/Book N/A
Trade ARYD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.02 +1.63%
on 01/30/24
11.27 -0.62%
on 02/14/24
+0.20 (+1.82%)
since 01/18/24
3-Month
10.85 +3.23%
on 12/29/23
11.27 -0.62%
on 02/14/24
+0.34 (+3.13%)
since 11/17/23
52-Week
10.18 +10.02%
on 02/24/23
11.27 -0.62%
on 02/14/24
+0.98 (+9.59%)
since 02/21/23

Most Recent Stories

More News
ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition...

ARYD : 11.20 (-0.18%)
FOLD : 13.56 (-1.02%)
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”

Business Combination of Amicus Gene Therapy Business with ARYA IV to Result  in the Launch of Caritas Therapeutics, a New Independent, Publicly Traded Company  with Expected ~$400M in Initial Funding...

ARYD : 11.20 (-0.18%)
FOLD : 13.56 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ARYA Sciences Acquisition Corp IV entered into a definitive business combination agreement with Amicus Therapeutics Inc.

See More

Key Turning Points

3rd Resistance Point 11.24
2nd Resistance Point 11.22
1st Resistance Point 11.21
Last Price 11.20
1st Support Level 11.19
2nd Support Level 11.17
3rd Support Level 11.16

See More

52-Week High 11.27
Last Price 11.20
Fibonacci 61.8% 10.85
Fibonacci 50% 10.73
Fibonacci 38.2% 10.60
52-Week Low 10.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar